Regenerative Medical Technology Group Inc. (RMTG) stock
RMTGOTCRetail-Retail Stores, NECFiscal year ends December 31
$0.04−0.00 (-5.76%)
Close on Oct 19, 2026Market cap $497.25KP/E –Yield –
Regenerative Medical Technology gross margin
Gross margin is gross profit as a percentage of revenue.
Regenerative Medical Technology's gross margin for the twelve months ending Jun 30, 2026 was 59.8%. For fiscal 2025 it was 55.1%, against 68.7% the year before. The highest annual figure on record is 83.6% in fiscal 2017.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 55.1% | −13.6 |
| FY2024 | Dec 31, 2024 | 68.7% | −0.8 |
| FY2023 | Dec 31, 2023 | 69.5% | +12.2 |
| FY2022 | Dec 31, 2022 | 57.3% | +23.0 |
| FY2021 | Dec 31, 2021 | 34.3% | +14.1 |
| FY2020 | Dec 31, 2020 | 20.2% | +104.6 |
| FY2019 | Dec 31, 2019 | -84.4% | −48.1 |
| FY2018 | Dec 31, 2018 | -36.4% | −119.9 |
| FY2017 | Dec 31, 2017 | 83.6% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 64.1% | +4.5 |
| Q1 FY2026 | Mar 31, 2026 | 66.9% | −2.3 |
| Q4 FY2025 | Dec 31, 2025 | 49.6% | −15.3 |
| Q3 FY2025 | Sep 30, 2025 | 42.5% | −33.3 |
| Q2 FY2025 | Jun 30, 2025 | 59.6% | −6.9 |
| Q1 FY2025 | Mar 31, 2025 | 69.2% | −0.5 |
| Q4 FY2024 | Dec 31, 2024 | 64.9% | −5.7 |
| Q3 FY2024 | Sep 30, 2024 | 75.7% | +6.1 |
| Q2 FY2024 | Jun 30, 2024 | 66.4% | −3.8 |
| Q1 FY2024 | Mar 31, 2024 | 69.6% | +1.4 |
| Q4 FY2023 | Dec 31, 2023 | 70.6% | +7.3 |
| Q3 FY2023 | Sep 30, 2023 | 69.6% | −2.4 |
| Q2 FY2023 | Jun 30, 2023 | 70.2% | +20.8 |
| Q1 FY2023 | Mar 31, 2023 | 68.3% | +32.7 |
| Q4 FY2022 | Dec 31, 2022 | 63.4% | +31.7 |
| Q3 FY2022 | Sep 30, 2022 | 72.0% | +25.7 |
| Q2 FY2022 | Jun 30, 2022 | 49.4% | +24.6 |
| Q1 FY2022 | Mar 31, 2022 | 35.6% | +268.5 |
| Q4 FY2021 | Dec 31, 2021 | 31.7% | +24.9 |
| Q3 FY2021 | Sep 30, 2021 | 46.4% | +31.2 |
| Q2 FY2021 | Jun 30, 2021 | 24.8% | −9.5 |
| Q1 FY2021 | Mar 31, 2021 | -232.9% | −225.8 |
| Q4 FY2020 | Dec 31, 2020 | 6.8% | −34.4 |
| Q3 FY2020 | Sep 30, 2020 | 15.1% | +269.4 |
| Q2 FY2020 | Jun 30, 2020 | 34.3% | +142.6 |
| Q1 FY2020 | Mar 31, 2020 | -7.1% | +24.8 |
| Q4 FY2019 | Dec 31, 2019 | 41.2% | +376.3 |
| Q3 FY2019 | Sep 30, 2019 | -254.2% | −296.4 |
| Q2 FY2019 | Jun 30, 2019 | -108.3% | −144.5 |
| Q1 FY2019 | Mar 31, 2019 | -31.8% | −106.5 |
| Q4 FY2018 | Dec 31, 2018 | -335.1% | – |
| Q3 FY2018 | Sep 30, 2018 | 42.2% | – |
| Q2 FY2018 | Jun 30, 2018 | 36.2% | – |
| Q1 FY2018 | Mar 31, 2018 | 74.7% | – |
See a number that looks wrong?